|
07-25-2010, 03:51 PM
|
|||
|
|||
Einstein Receives $4 Million To Test HPV Microbicide
The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard against the human papillomavirus (HPV), which causes cervical cancer. The research will evaluate the efficacy of Carraguard, a clear gel made from the seaweed derivative carrageenan in preventing new HPV infections in women. According to the World ...
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| U receives $26 million for bone marrow transplant cancer research | cancerfr | Bone Cancer | 0 | 09-22-2010 07:11 PM |
| UT Southwestern receives $8 million NIH grant to study influence of brain and liver o | cancerfr | Brain Tumor | 0 | 09-15-2010 08:26 PM |
| L.A. cancer program receives $23.5 million | cancerfr | Latest Cancer News | 0 | 09-02-2010 10:56 PM |
| Albert Einstein College of Medicine receives research grant to help people with MDR-T | cancerfr | AIDS-related cancer | 0 | 08-04-2010 06:54 AM |
Linear Mode
